- Home
- ANIX vs VGI Comparison
ANIX vs VGI Comparison
Compare ANIX & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- VGI
- Stock Information
- Founded
- ANIX 1982
- VGI 2012
- Country
- ANIX United States
- VGI United States
- Employees
- ANIX N/A
- VGI N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- ANIX Health Care
- VGI Finance
- Exchange
- ANIX Nasdaq
- VGI Nasdaq
- Market Cap
- ANIX 82.7M
- VGI 91.4M
- IPO Year
- ANIX 1987
- VGI N/A
- Fundamental
- Price
- ANIX $2.41
- VGI $7.68
- Analyst Decision
- ANIX Strong Buy
- VGI
- Analyst Count
- ANIX 2
- VGI 0
- Target Price
- ANIX $8.50
- VGI N/A
- AVG Volume (30 Days)
- ANIX 121.1K
- VGI 46.0K
- Earning Date
- ANIX 01-10-2025
- VGI 01-01-0001
- Dividend Yield
- ANIX N/A
- VGI 12.66%
- EPS Growth
- ANIX N/A
- VGI N/A
- EPS
- ANIX N/A
- VGI N/A
- Revenue
- ANIX N/A
- VGI N/A
- Revenue This Year
- ANIX N/A
- VGI N/A
- Revenue Next Year
- ANIX N/A
- VGI N/A
- P/E Ratio
- ANIX N/A
- VGI N/A
- Revenue Growth
- ANIX N/A
- VGI N/A
- 52 Week Low
- ANIX $2.07
- VGI $6.68
- 52 Week High
- ANIX $5.09
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- ANIX 44.08
- VGI 44.73
- Support Level
- ANIX $2.07
- VGI $7.50
- Resistance Level
- ANIX $2.69
- VGI $7.70
- Average True Range (ATR)
- ANIX 0.19
- VGI 0.11
- MACD
- ANIX 0.03
- VGI 0.01
- Stochastic Oscillator
- ANIX 54.84
- VGI 60.00
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.